HeartSciences Inc.
HSCS
$3.70
$0.010.27%
NASDAQ
| 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -66.13% | -76.34% | -100.00% | 149.15% | 830.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -66.13% | -76.34% | -100.00% | 149.15% | 830.00% |
| Cost of Revenue | -55.74% | -68.85% | -100.00% | 100.00% | 662.50% |
| Gross Profit | -71.20% | -80.00% | -100.00% | 180.56% | 941.67% |
| SG&A Expenses | 13.36% | 15.39% | 3.78% | 5.59% | 3.01% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.39% | 32.14% | 37.54% | 28.65% | 17.52% |
| Operating Income | -15.60% | -32.46% | -37.97% | -28.53% | -17.25% |
| Income Before Tax | -20.28% | -32.70% | -33.26% | -25.20% | -18.58% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -20.28% | -32.70% | -33.26% | -25.20% | -18.58% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -20.28% | -32.70% | -33.26% | -25.20% | -18.58% |
| EBIT | -15.60% | -32.46% | -37.97% | -28.53% | -17.25% |
| EBITDA | -15.67% | -32.45% | -37.90% | -28.53% | -17.25% |
| EPS Basic | 65.67% | 73.03% | 78.96% | 82.75% | 64.32% |
| Normalized Basic EPS | 65.66% | 73.03% | 78.96% | 82.75% | 64.32% |
| EPS Diluted | 65.67% | 73.03% | 78.96% | 82.75% | 64.32% |
| Normalized Diluted EPS | 65.66% | 73.03% | 78.96% | 82.75% | 64.32% |
| Average Basic Shares Outstanding | 105.00% | 165.65% | 289.14% | 637.61% | 472.20% |
| Average Diluted Shares Outstanding | 105.00% | 165.65% | 289.14% | 637.61% | 472.20% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |